| NCT ID | NCT05635123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Women's Hospital School Of Medicine Zhejiang University |
| Condition | Cervical Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,200 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,200 participants in total. It began in 2023-09-15 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.
Eligibility Criteria
Inclusion Criteria: * Age 20-75 years; * Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time; * Women attending a health check-up; * Obtain informed consent and sign an informed consent form. Exclusion Criteria: * Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment； * Patients with cancer other than cervical cancer or endometrial cancer; * Women who have received hysterectomy or pelvic radiation therapy previously.
Contact & Investigator
Hui Wang, PhD
PRINCIPAL INVESTIGATOR
Women's Hospital School Of Medicine Zhejiang University
Frequently Asked Questions
Who can join the NCT05635123 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 75 Years, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05635123 currently recruiting?
Yes, NCT05635123 is actively recruiting participants. Contact the research team at wang71hui@zju.deu.cn for enrollment information.
Where is the NCT05635123 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT05635123 clinical trial?
NCT05635123 is sponsored by Women's Hospital School Of Medicine Zhejiang University. The principal investigator is Hui Wang, PhD at Women's Hospital School Of Medicine Zhejiang University. The trial plans to enroll 6,200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.